David Einhorn recent buys & sells (2023 Q4)
Greenlight Capital
Greenlight Capital Portfolio Changes
Purchase & sale details
- Portfolio value:
- $2.05B (+$287M)
- Previous value:
- $1.76B
- # of changes:
- 37
- New positions:
- 7
- Reported for:
- 31 Dec 2023 (Q4)
- Latest filing date:
- 14 Feb 2024
Greenlight Capital has disclosed a total of 37 changes to the portfolio in the (2023 Q4) SEC report(s): increased the number of shares of 20, bought 7 totally new, decreased the number of shares of 4 and completely sold out 6 position(s).
What stocks did David Einhorn buy in 2023 Q4?
During 2023 Q4 David Einhorn has bought 27 securities out of which top 5 purchases (by % change to portfolio) were (KD) Kyndryl Holdings Inc (added shares +13.74%), (THC) Tenet Healthcare Corp (added shares +44.33%), (ODP) ODP Corp (added shares +8.29%), (ALIT) Alight Inc (new buy) and (TECK) Teck Resources Ltd, CL-B (added shares +6.17%).
What did David Einhorn invest in during 2023 Q4?
In the 2023 Q4 report(s) the following changes have been made to the top investments: (GRBK) Green Brick Partners Inc (reduced shares -7.60%), (CNR) Core Natural Resources, Inc (reduced shares -12.42%), (BHF) Brighthouse Financial, Inc (reduced shares -3.15%), (KD) Kyndryl Holdings Inc (added shares +13.74%) and (THC) Tenet Healthcare Corp (added shares +44.33%).
37 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AERCAP HOLDINGS NV
|
new
|
+250,000
|
250,000
|
+0.91%
|
$74.32
|
+114.11%($159.12)
|
0.91%
|
2023 Q4
|
~0.25 years
|
|
|
|
Alight Inc
|
new
|
+462,083.5
|
462,083.5
|
+3.85%
|
$170.60
|
-94.55%($9.30)
|
3.85%
|
2023 Q4
|
~0.25 years
|
|
|
|
Invesco Aerospace & Defense ETF
|
new
|
+185,521
|
185,521
|
+0.83%
|
$92.16
|
+76.22%($162.40)
|
0.83%
|
2023 Q4
|
~0.25 years
|
|
|
|
Kenvue Inc
|
new
|
+554,490
|
554,490
|
+0.58%
|
$21.53
|
-9.92%($19.40)
|
0.58%
|
2023 Q4
|
~0.25 years
|
|
|
|
SPDR S&P Aerospace & Defense ETF
|
new
|
+129,667
|
129,667
|
+0.86%
|
$135.42
|
+74.30%($236.04)
|
0.86%
|
2023 Q4
|
~0.25 years
|
|
|
|
Teva Pharma Industries Ltd ADR
|
new
|
+268,470
|
268,470
|
+0.14%
|
$10.44
|
+296.41%($41.38)
|
0.14%
|
2023 Q4
|
~0.25 years
|
|
|
|
Viatris Inc
|
new
|
+3,355,770
|
3,355,770
|
+1.77%
|
$10.83
|
+75.76%($19.04)
|
1.77%
|
2023 Q4
|
~0.25 years
|
|
|
|
Coya Therapeutics, Inc
|
+172.19%
|
+805,959
|
1,274,026
|
+0.29%
|
$7.41
|
-44.67%($4.10)
|
0.46%
|
2022 Q4
|
~1.25 years
|
|
|
|
DHT HOLDINGS INC
|
+86.68%
|
+1,755,060
|
3,779,880
|
+0.84%
|
$9.81
|
+156.78%($25.19)
|
1.81%
|
2023 Q3
|
~0.50 years
|
|
|
|
SEADRILL LIMITED
|
+51.14%
|
+184,040
|
543,935
|
+0.42%
|
$47.28
|
+9.37%($51.71)
|
1.26%
|
2023 Q2
|
~0.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".